Here, APOA5 demonstrated a strong protective effect against MI and MetS, consistent with findings that APOA5 knockout mice display a fourfold elevation in plasma triglyceride levels41, a significant risk factor for ACVD42. This evidence concerns the gene APOA5 and myocardial infarction.